Lia Mayorga
Mendoza, M, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rewriting nuclear epigenetic scripts in mitochondrial diseases as a strategy for heteroplasmy control.
Journal: EMBO molecular medicine
Published: April 01, 2025
Rewriting nuclear epigenetic scripts in mitochondrial diseases as a strategy for heteroplasmy control.
Journal: bioRxiv : the preprint server for biology
Published: January 13, 2025
PURA and GLUT1: Sweet partners for brain health.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 26, 2023
Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients.
Journal: Molecular genetics and metabolism reports
Published: December 04, 2020
PURA-Related Developmental and Epileptic Encephalopathy: Phenotypic and Genotypic Spectrum.
Journal: Neurology. Genetics
Published: November 03, 2020
A modelling study highlights the power of detecting and isolating asymptomatic or very mildly affected individuals for COVID-19 epidemic management.
Journal: BMC public health
Published: June 05, 2020
Mitochondrial stress triggers a pro-survival response through epigenetic modifications of nuclear DNA.
Journal: Cellular and molecular life sciences : CMLS
Published: August 14, 2018
A frame-shift deletion in the PURA gene associates with a new clinical finding: Hypoglycorrhachia. Is GLUT1 a new PURA target?
Journal: Molecular genetics and metabolism
Published: November 01, 2017
Mitochondrial DNA deletions detected by Multiplex Ligation-dependent Probe Amplification.
Journal: Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis
Published: June 27, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026